Navigation Links
Invivotek Awarded Full AAALAC Accreditation for Excellence in Laboratory Animal Care and Use
Date:7/14/2014

HAMILTON, N.J., July 14, 2014 /PRNewswire/ -- Invivotek L.L.C., a member of the Genesis Biotechnology Group, LLC is pleased to announce that its animal research facility was awarded full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). AAALAC promotes the humane treatment of animals in science worldwide through voluntary accreditation and assessment programs. AAALAC recognizes the highest standards for animal care and use in 38 countries.

Invivotek was established in 2012. In 2013, Invivotek received the Innovation and Achievement Award from Allentown, Inc. for its excellence in animal facility design, planning, construction and operations. As an AAALAC accredited facility, Invivotek provides further assurance to Invivotek's pharmaceutical and biotechnology clients of its commitment to setting, achieving and maintaining the highest standards for animal welfare in science.

In announcing the award of full accreditation, AAALAC's Council on Accreditation specifically commended Invivotek for its "excellent program of laboratory animal care and use." The Council also commented on Invivotek's impeccably clean and well maintained facilities, its design, high quality architectural finishes and excellent equipment and Invivotek's strong commitment to the highest accreditation standards. The Council also recognized "the knowledge, experience and dedication of the Facility Manager."

Invivotek is located in "Einstein's Alley," the research and technology corridor in Hamilton, New Jersey, which is easily accessible to biotech and pharmaceutical companies and academic biomedical centers in New York, New Jersey, and Pennsylvania. Invivotek offers both custom and standard pre-clinical services to support drug discovery and development programs for its clients. The company portfolio includes bioassays designed to support in vivo testing of compounds related to immunology and inflammation, cancer, diabetes, cardiovascular, obesity, neurodegenerative disorders and other diseases and conditions. Invivotek's in vivo testing capabilities are supported by biochemical and molecular biology techniques, as well as functional assays using primary cell cultures established from various animal tissues under disease model and normal conditions. These assays provide tools to study mechanisms of action of various test therapeutics or potential target genes and to explore drug efficacy biomarkers.

Invivotek is a member of the Genesis Biotechnology Group® (GBG), a consortium of vertically integrated entities pursuing clinical diagnostic testing, preclinical and translational research, and the manufacturing and distribution of life science products. GBG's combined research scientific community creates and sustains drug development and diagnostic programs for targeting infectious, metabolic, inflammatory, and autoimmune diseases, as well as cancer and other issues relating to women's health.

To find out more, please visit www.invivotek.com

Contact:

Dr. Olesia Buiakova
Chief Scientific Officer
Ph: (609) 249-9565
Email


'/>"/>
SOURCE Invivotek
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Invivotek Receives Distinguished Innovation and Achievement Award from Allentown, Inc., the Leader in Design and Installation for Quality Animal Housing
2. University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services
3. CorMedix Awarded European Patent for Neutrolin
4. Luoxis Awarded ISO 13485:2003 and ISO 9001:2008 Certifications
5. Puritan Medical Products Awarded Two New Flocked Swab Patents in Japan
6. West Physics Consulting Residency Program Awarded CAMPEP Accreditation
7. Educational Grant Awarded to Winner of Ferring Pharmaceuticals Inaugural Heart to Heart Video Contest
8. Marken Singapore Awarded Quality Management Certification
9. Boston Engineering Corporation awarded ISO 9001 and ISO 13485 certifications
10. Sanovas Awarded Patent for Abrading Balloon Catheter for Extravasated Drug Delivery
11. WPPS GO Team Awarded Tums and Eno Global Account by GlaxoSmithKline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):